Fractionated Stereotactic Radiotherapy using CyberKnife for the Treatment of Large Brain Metastases: A Dose Escalation Study

Clinical Oncology - Tập 26 - Trang 151-158 - 2014
T. Murai1,2, H. Ogino3, Y. Manabe1, M. Iwabuchi1, T. Okumura4, Y. Matsushita4, Y. Tsuji4, H. Suzuki5, Y. Shibamoto1
1Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
2Department of Radiation Oncology, Yokohama CyberKnife Center, Yokohama, Japan
3Nagoya Proton Therapy Center, Nagoya, Japan
4Department of Neurosurgery, Tsushima City Hospital, Tsushima, Japan
5Department of Radiology, Tsushima City Hospital, Tsushima, Japan

Tài liệu tham khảo

Nieder, 2011, Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years?, Cancer, 117, 2505, 10.1002/cncr.25707 Tsao, 2012, International practice survey on the management of brain metastases: Third International Consensus Workshop on Palliative Radiotherapy and Symptom Control, Clin Oncol (R Coll Radiol), 24, e81, 10.1016/j.clon.2012.03.008 Serizawa, 2009, Radiosurgery for metastatic brain tumors, Int J Clin Oncol, 14, 289, 10.1007/s10147-009-0910-7 Shibamoto, 2009, Radiotherapy for metastatic brain tumors, Int J Clin Oncol, 14, 281, 10.1007/s10147-009-0915-2 Linskey, 2010, The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline, J Neurooncol, 96, 45, 10.1007/s11060-009-0073-4 Gaspar, 2010, The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline, J Neurooncol, 96, 17, 10.1007/s11060-009-0060-9 Kalkanis, 2010, The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline, J Neurooncol, 96, 33, 10.1007/s11060-009-0061-8 Kwon, 2009, Hypofractionated stereotactic radiotherapy for the treatment of brain metastases, Cancer, 115, 890, 10.1002/cncr.24082 Kjellberg, 1983, Bragg-peak proton-beam therapy for arteriovenous malformations of the brain, N Engl J Med, 309, 269, 10.1056/NEJM198308043090503 Flickinger, 2000, Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group, Int J Radiat Oncol Biol Phys, 46, 1143, 10.1016/S0360-3016(99)00513-1 Kilby, 2010, The CyberKnife robotic radiosurgery system in 2010, Technol Cancer Res Treat, 9, 433, 10.1177/153303461000900502 Iwata, 2011, Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity, Neuro Oncol, 13, 916, 10.1093/neuonc/nor055 Macdonald, 1990, Response criteria for phase II studies of supratentorial malignant glioma, J Clin Oncol, 8, 1277, 10.1200/JCO.1990.8.7.1277 Wen, 2010, Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group, J Clin Oncol, 28, 1963, 10.1200/JCO.2009.26.3541 Gaspar, 1997, Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, 37, 745, 10.1016/S0360-3016(96)00619-0 Scrucca, 2010, Regression modeling of competing risk using R: an in depth guide for clinicians, Bone Marrow Transplant, 45, 1388, 10.1038/bmt.2009.359 Fowler, 2010, 21 years of biologically effective dose, Br J Radiol, 83, 554, 10.1259/bjr/31372149 R, 2011 Rampling, 1994, Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors, Int J Radiat Oncol Biol Phys, 29, 427, 10.1016/0360-3016(94)90432-4 Shibamoto, 1986, Variation in the hypoxic fraction among mouse tumors of different types, sizes, and sites, Jpn J Cancer Res, 77, 908 Murata, 1996, Reoxygenation after single irradiation in rodent tumors of different types and sizes, Int J Radiat Oncol Biol Phys, 34, 859, 10.1016/0360-3016(95)02155-8 Kim, 2011, Single-dose versus fractionated stereotactic radiotherapy for brain metastases, Int J Radiat Oncol Biol Phys, 81, 483, 10.1016/j.ijrobp.2010.05.033 Higuchi, 2009, Three-staged stereotactic radiotherapy without whole brain irradiation for large metastatic brain tumors, Int J Radiat Oncol Biol Phys, 74, 1543, 10.1016/j.ijrobp.2008.10.035 Fahrig, 2007, Hypofractionated stereotactic radiotherapy for brain metastases – results from three different dose concepts, Strahlenther Onkol, 183, 625, 10.1007/s00066-007-1714-1 Jiang, 2012, Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters, Radiat Oncol, 7, 36, 10.1186/1748-717X-7-36 Wegner, 2013, Fractionated stereotactic radiosurgery for large brain metastases, Am J Clin Oncol Shibamoto, 2012, Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model, J Radiat Res (Tokyo), 53, 1, 10.1269/jrr.11095 Shibamoto, 2012, Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study, Cancer, 118, 2078, 10.1002/cncr.26470 Otsuka, 2011, Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor, Int J Radiat Oncol Biol Phys, 81, 1538, 10.1016/j.ijrobp.2011.05.034 Tsao, 2012, A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases, Cancer, 118, 2486, 10.1002/cncr.26515 Andrews, 2004, Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial, Lancet, 363, 1665, 10.1016/S0140-6736(04)16250-8